CRIS: the cashflow

MyFinsight

For the quarter ending 2025-09-30, CRIS had -$1,087K decrease in cash & cash equivalents over the period.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-7,729	-19,209
Depreciation and amortization	32	101
Non-cash lease expense	322	620
Stock-based compensation expense	924	2,299
Non-cash activity related to the sale of future royalties	41	3
Amortization of premiums and discounts on investments	0	0
Accounts receivable	491	-597
Prepaid expenses and other assets	-643	-854
Accounts payable and accrued liabilities	1,030	119
Operating lease liability	-341	-645
Total adjustments	2,160	3,948
Net cash used in operating activities	-5,569	-15,261
Purchase of investments	0	0
Sales and maturities of investments	0	0
Net cash provided by investing activities	0	0
Proceeds from issuance of common stock, pre-funded warrants, and common warrants, net of issuance costs	6,049	9,422
Payment of liability of future royalties, net of imputed interest	1,567	4,020
Net cash provided by (used in) financing activities	4,482	5,402
Net decrease in cash and cash equivalents and restricted cash	-1,087	-9,859
Cash and cash equivalents at beginning of period	20,541	-
Cash and cash equivalents at end of period	9,595	-

Unit: Thousand (K) dollars